Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cyproheptadine (periactin) (1 trial)
methylphenidate (ritalin) (1 trial)
Attention Deficit and Disruptive Behavior Disorders (Phase 4)
Attention Deficit Disorder with Hyperactivity (Phase 4)
Disease (Phase 4)
Hyperkinesis (Phase 4)
Mental Disorders (Phase 4)
Neurodevelopmental Disorders (Phase 4)
Problem Behavior (Phase 4)
Trials (1 total)
Trial APIs (2 total)